Vanguard Group’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Sell |
|
|||||
|
2025
Q1 | $222K | Sell |
|
|||||
|
2024
Q4 | $368K | Buy |
|
|||||
|
2024
Q3 | $457K | Buy |
|
|||||
|
2024
Q2 | $479K | Buy |
|
|||||
|
2024
Q1 | $9.21M | Buy |
|
|||||
|
2023
Q4 | $5.61M | Buy |
|
|||||
|
2023
Q3 | $3.38M | Buy |
|
|||||
|
2023
Q2 | $3.25M | Hold |
|
|||||
|
2023
Q1 | $1.59M | Hold |
|
|||||
|
2022
Q4 | $2.48M | Buy |
|
|||||
|
2022
Q3 | $3.96M | Buy |
|
|||||
|
2022
Q2 | $3.82M | Buy |
|
|||||
|
2022
Q1 | $879K | Hold |
|
|||||
|
2021
Q4 | $954K | Sell |
|
|||||
|
2021
Q3 | $2.01M | Hold |
|
|||||
|
2021
Q2 | $1.77M | Buy |
|
|||||
|
2021
Q1 | $2.46M | Buy |
|
|||||
|
2020
Q4 | $1.98M | Buy |
|
|||||
|
2020
Q3 | $1.7M | Buy |
|
|||||
|
2020
Q2 | $393K | Buy |
|